Discovery of key protein behind cancer relapse and progression can lead to new therapies

(Duke-NUS Medical School) Reports show that cancer is the second-highest leading cause of death globally. A recent study by scientists from Duke-NUS Medical School provides new evidence supporting the presence of a key mechanism behind progression and relapse in cancer. The study, published in Proceedings of the National Academy of Sciences (PNAS), discusses the role of MBNL1 protein as a biomarker for cancer prognosis, which can lead to the development of new treatment strategies for cancer.